Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Proxy Governance, Inc. was a prominent independent proxy advisory firm that provided research, analysis, and voting recommendations to institutional investors on corporate governance matters. Founded in 2004 by former SEC Commissioner Steven Wallman, the firm offered an online voting platform called Proxy Advantage and was a key competitor to firms like ISS and Glass Lewis. The company was frequently involved in high-profile proxy contests and mergers within the life sciences and healthcare sectors, providing critical guidance during shareholder votes for companies such as Genzyme, Biovail, and Charles River Laboratories. In 2011, Proxy Governance was acquired by Ernst & Young (EY), which integrated the firm's expertise and database into its newly formed Corporate Governance Group.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Proxy Governance.